NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 8, 2019

Primary Completion Date

March 30, 2021

Study Completion Date

June 30, 2021

Conditions
Acute PainArthropathy of KneeArthropathy of HipPain, PostoperativeKidney Transplant DonorBariatric Surgery Candidate
Interventions
DEVICE

NSS-2 Bridge

The NSS-2 BRIDGE is a battery operated and disposable percutaneous auricular nerve field stimulator (Innovative Health Solutions, Versailles, IN, USA), that was recently cleared by the FDA and assigned a Class II Risk Designation; a class which includes surgical drapes, pumps and power wheelchairs. The indication for the NSS-2 BRIDGE is for the treatment of clinical symptoms related to opioid consumption and opioid withdrawal.

Trial Locations (3)

15213

UPMC Magee-Womens Hospital, Pittsburgh

UPMC Presbyterian, Pittsburgh

15232

UPMC Shadyside Hospital, Pittsburgh

All Listed Sponsors
lead

Jacques E. Chelly

OTHER

NCT03834142 - NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries | Biotech Hunter | Biotech Hunter